Trial Site Detail
Drug: |
CB-839 |
|||
|---|---|---|---|---|
Trial: |
Study of the Glutaminase Inhibitor CB-839 in Solid Tumors |
|||
| Conditions: | Solid Tumors | |||
Trial Status: |
Active, not recruiting |
|||
Beth Israel Deaconess Medical Center330 Brookline Ave. |
Principal Investigator: |
James W Mier, MD |
|---|---|
Contact: |
Susan Gotthardt, RN 617-632-9272 |
Activation Status of this Site: |
Closed |
Notes about this Site: |
|
Beth Israel Deaconess Medical Center Website: |
http://www.bidmc.org/Research/Departments/Medicine/Divisions/HematologyOncology/PhaseIInvestigationalGroup.aspx |
Navigating the Map
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.